Colorectal Cancer Stage III Clinical Trial
Official title:
the Role of ctDNA in Predicting the Recurrence Risk of Stage Ⅱ and Ⅲ Colorectal Cancer and the Dynamic Changes in ctDNA of Patients With Adjuvant Chemotherapy
The purpose of this study was to observe the relationship between ctDNA as a molecular marker of colorectal cancer and the risk of postoperative recurrence.
In this clinical study, ctDNA will be detected in postoperative patients with stage Ⅱ and Ⅲ colorectal cancer to evaluate the correlation between ctDNA and the risk of postoperative recurrence. According to the dynamic changes of ctDNA after adjuvant chemotherapy, the correlation between ctDNA and postoperative DFS will be compared, and the feasibility of ctDNA as a molecular marker to evaluate the risk of postoperative recurrence of colorectal cancer will be investigated. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01570452 -
Matrilysin Expression in Different Stages of Colorectal Tumors
|
N/A | |
| Active, not recruiting |
NCT04304209 -
Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT04398446 -
Effect of Hemp-CBD on Patients With CIPN
|
Phase 2 | |
| Recruiting |
NCT04486378 -
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
|
Phase 2 | |
| Recruiting |
NCT04264676 -
Study of Oral Metronidazole on Postoperative Chemotherapy in Colorectal Cancer
|
Phase 2 | |
| Recruiting |
NCT06314958 -
Stage II/III Colorectal Cancer Recurrence
|
||
| Recruiting |
NCT06342440 -
Early Detection of Advanced Adenomas and Colorectal Cancer
|
||
| Recruiting |
NCT04714814 -
Mechanisms of Fate Evolution of Colorectal Adenocarcinoma Metastasis
|
||
| Recruiting |
NCT05898789 -
Virtual Rehabilitation for Cancer Survivors
|
N/A | |
| Completed |
NCT01356264 -
Multimodal Prehabilitation for Colorectal Surgery
|
Phase 2 | |
| Recruiting |
NCT04813627 -
Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy
|
||
| Recruiting |
NCT03448549 -
SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients
|
Phase 3 | |
| Recruiting |
NCT03904537 -
A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06111105 -
Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer
|
||
| Recruiting |
NCT06076811 -
DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies
|
||
| Recruiting |
NCT06342401 -
Early Onset Colorectal Cancer Detection
|
||
| Completed |
NCT06271980 -
Early-Onset Colorectal Cancer Recurrence
|